野村:維持中國人保(1339.HK)“買入”評級 目標價4.25港元
野村發佈報告稱,維持對中國人保(01339.HK)的“買入”的投資評級,目標價4.25港元不變。該行表示,人保制定及開始實施“3411工程”,透過轉型推動業務高質量發展,包括以專業化提升業務價值、利用科技釋放價值,以及在城市中提升市佔率等。
該行稱,在財險業務方面,人保長期目標是綜合成本率達95%,非車險業務的佔比由現時的43%提升至60%。至於壽險業務方面,人保管理層稱今年上半年新業務價值同比上升25.6%,高於同業水平,並希望業務轉型帶動未來三至五年的新業務價值提升至更高水平。另外,該行引述人保稱,希望可以透過提出科技能力達至業務擴張和提升用户體驗,冀人民的健康應用程式在2021年註冊用户數達到1億,活躍用户數達到500萬。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.